Business Context and Reporting Period
Company: American Shared Hospital Services (ASHS)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2008
Business Overview: ASHS provides Gamma Knife radiosurgery units and radiation therapy equipment to medical centers. As of March 31, 2008, the company operated 19 Gamma Knife units across 19 medical centers. The company also holds a significant investment in Still River Systems, Inc., a developer of proton beam radiation therapy systems.
Key Financial Metrics
| Metric | Q1 2008 | Q1 2007 |
|---|---|---|
| Medical Services Revenue | $4,725,000 | $4,749,000 |
| Gross Margin | $2,069,000 (43.8%) | $2,230,000 (47.0%) |
| Operating Income | $394,000 | $602,000 |
| Net Income | $156,000 | $225,000 |
| Diluted EPS | $0.03 | $0.04 |
| Cash and Cash Equivalents | $6,292,000 | $3,221,000 (End of Q1 2007) |
| Net Cash from Operating Activities | $1,563,000 | $1,948,000 |
| Total Debt (Current + Long-term) | $28,976,000 | N/A |
| Working Capital | $2,609,000 | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased by $24,000 (0.5%) primarily due to the expiration of two Gamma Knife contracts and extended downtime for three units undergoing upgrades or cobalt reloads. This was partially offset by $364,000 in revenue from a new radiation therapy contract.
- Profitability Decrease: Net income fell 30.7% to $156,000. Operating income dropped 34.6% to $394,000.
- Cost Increases: Total costs of revenue rose $137,000. Depreciation and amortization increased by $105,000 due to new equipment and upgrades. Interest expense increased by $101,000 to $568,000, driven by financing for new radiation therapy equipment and Gamma Knife upgrades.
- Asset Base: Total assets increased slightly to $63,593,000. A significant portion of "Other receivables" ($1,473,000) relates to proceeds from a Gamma Knife sale expected in Q2 2008.
Outlook, Risks, and Management Commentary
- Operational Status: The company reduced its operational Gamma Knife count to 18 units effective April 1, 2008, after a customer exercised an early termination option to purchase their unit. Procedures decreased to 477 in Q1 2008 from 607 in Q1 2007.
- Capital Commitments: ASHS has approximately $25,000,000 in remaining commitments to purchase equipment, including two Monarch 250 Proton Beam Radiation Therapy (PBRT) systems from Still River Systems, two Perfexion Gamma Knife units, and one LGK Model 4 unit.
- Investment Risk: The company holds a $2,617,000 preferred stock investment in Still River Systems. The PBRT systems are not yet FDA approved, and the company reviews these deposits for impairment quarterly. There is no assurance of FDA approval or commercial success.
- Liquidity: Management believes cash flow from operations and existing resources are adequate to meet debt obligations for the next 12 months. The company maintains a $6,000,000 line of credit with $4,100,000 currently drawn.
- Market Risk: The company does not hold derivative instruments and has no significant long-term market-sensitive investments.
Key Facts for Investor Verification
- Contract Renewals: Verify the status of the two Gamma Knife contracts that expired in late 2007/early 2008 and the potential for new contracts to replace lost revenue.
- Still River Systems Progress: Monitor the FDA approval timeline for the Monarch 250 PBRT systems, as the $25M equipment commitment relies on this approval.
- Equipment Downtime: Assess the duration of downtime for the three units undergoing upgrades and the impact on future quarterly revenue.
- Debt Service: Confirm the company's ability to service approximately $9.5M in scheduled debt payments and $1.4M in capital lease payments over the next 12 months.
- Receivables Collection: Verify the collection of the $1,473,000 receivable from the Gamma Knife sale recorded in Q1 2008.